Emily J. Aller

Also affiliated with The University of Texas at San Antonio

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling”.

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling

International Journal of Molecular Sciences(2023)10.3390/ijms242417426

N/A

0DataRank · unranked

13 citations

Alondra L. Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy Medina, Xue Yang +11 more

Significance of Midkine Signaling in Women’s Cancers: Novel Biomarker and Therapeutic Target

International Journal of Molecular Sciences(2025)10.3390/ijms26104809

N/A

0DataRank · unranked

13 citations

Hareesh B. Nair, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli, Emily J. Aller

Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis

Cancers(2025)10.3390/cancers17050790

N/A

0DataRank · unranked

1 citations

Zenaida Fuentes, Lois Randolph, Megharani Mahajan, Emily J. Aller, Behnam Ebrahimi +9 more